These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32640195)

  • 1. miR-124 regulates liver cancer stem cells expansion and sorafenib resistance.
    Feng Y; Jiang W; Zhao W; Lu Z; Gu Y; Dong Y
    Exp Cell Res; 2020 Sep; 394(2):112162. PubMed ID: 32640195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B; Liu D; Yang P; Li HY; Wang D
    Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway.
    Si A; Wang L; Miao K; Zhang R; Ji H; Lei Z; Cheng Z; Fang X; Hao B
    Cell Cycle; 2019 Dec; 18(24):3550-3561. PubMed ID: 31724462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway.
    Song S; Sun K; Dong J; Zhao Y; Liu F; Liu H; Sha Z; Mao J; Ding G; Guo W; Fu Z
    Exp Cell Res; 2020 Feb; 387(2):111781. PubMed ID: 31857112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
    Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
    Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1.
    Yang D; Zhang P; Yang Z; Hou G; Yang Z
    Carcinogenesis; 2024 Jul; 45(7):463-474. PubMed ID: 36437743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-365 regulates liver cancer stem cells via RAC1 pathway.
    Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT
    Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.
    Lei Z; Tang X; Si A; Yang P; Wang L; Luo T; Guo G; Zhang Q; Cheng Z
    Exp Cell Res; 2020 May; 390(1):111955. PubMed ID: 32165166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients.
    Li J; Zhong X; Wang X; Xu F; Yang J; Lu J; Liu C; Lu J
    Arch Biochem Biophys; 2021 May; 703():108871. PubMed ID: 33831356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance.
    Huang Y; Zhang J; Li H; Peng H; Gu M; Wang H
    J Cancer; 2020; 11(22):6545-6555. PubMed ID: 33046975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
    Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
    Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
    Han T; Zhang Y; Yang X; Han L; Li H; Chen T; Zheng Z
    Mol Ther Nucleic Acids; 2020 Mar; 19():1073-1085. PubMed ID: 32044726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
    Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
    Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
    Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
    J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
    Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
    Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway.
    Xia Q; Han T; Yang P; Wang R; Li H; Zhang J; Zhou X
    Stem Cells Int; 2019; 2019():8734362. PubMed ID: 31885628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.